The International Pharmaceutical Federation (FIP) has released a new global policy statement advocating for the ethical, evidence-based, and sustainable use of artificial intelligence in pharmacy. The document arrives at a critical moment, as AI continues to expand into health care delivery, supply chain optimisation, and clinical support.

The policy outlines a vision in which AI enhances, rather than replaces, the role of pharmacy professionals. It sets clear boundaries and expectations to ensure AI tools uphold patient safety, respect professional judgement, and support equitable access to care¹.

FIP defines AI as technologies that replicate human cognitive functions such as learning, decision-making, and language processing. These systems, including machine learning and robotics, are increasingly being used to support pharmacy operations, from inventory management to patient engagement. However, the policy emphasises that implementation must be guided by human oversight and governed by appropriate regulatory frameworks².

At the centre of the policy are 12 guiding principles that address transparency, accountability, privacy, inclusion, and workforce development. FIP encourages governments to introduce robust governance mechanisms and calls on pharmacy schools to integrate AI literacy into their training programs. Developers are also urged to involve pharmacists directly in the design and evaluation of AI tools, ensuring these technologies reflect the realities of day-to-day pharmacy practice².

The policy highlights potential risks alongside benefits. While AI can improve efficiency and reduce administrative burden, there are concerns around data bias, algorithmic transparency, and the potential for misuse. If deployed without appropriate safeguards, AI could exacerbate health inequities or reduce the quality of patient care. There is also a risk that commercial applications may prioritise cost savings over clinical outcomes, or automate decision-making in ways that undermine professional responsibility^1,2.

From a commercial and operational perspective, these insights are particularly relevant for Australian pharmacies already exploring AI-enabled tools for ordering, invoicing, and data analytics. As the sector continues to digitise, the policy serves as a framework for responsible adoption. It reinforces the need for human-centred design, clear accountability, and alignment with professional standards.